Skip to main content
SpringerLink
Log in

Strategisches Vorgehen bei pathologischen Frakturen

Strategic approach to pathological fractures

  • Leitthema
  • Published:
Der Unfallchirurg Aims and scope Submit manuscript

Zusammenfassung

Die pathologische tumorassoziierte Fraktur ist insgesamt selten. Sie kann in jedem Alter und Knochen auftreten. Obwohl tumorbedingte Frakturen nur einen geringen Anteil der Knochenfrakturen ausmachen, sind das rechtzeitige Erkennen der Frakturursache und die onkologisch leitliniengerechte Behandlung für den betroffenen Patienten von enormer Bedeutung. Fehlbehandlungen sind häufig mit weitreichenden negativen Konsequenzen hinsichtlich des Erkrankungsverlaufs assoziiert. Die große Herausforderung ist nicht die zügige operative Versorgung, sondern vielmehr die adäquate Diagnostik und das Einbinden der lokalen Frakturversorgung in ein interdisziplinäres onkologisches Gesamtkonzept.

Abstract

Pathological tumor-associated fractures are overall rare. They can occur in every age group and every bone. Although tumor-related fractures only form a small proportion of bone fractures, the early recognition of the cause of the fracture and treatment according to oncological guidelines are of enormous importance for affected patients. False treatment is frequently associated with far-reaching negative consequences with respect to the course of the disease. The great challenge is not the expeditious surgical treatment but much more the adequate diagnostics and the incorporation of local fracture treatment into an interdisciplinary overall oncological concept.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. GKV Spitzenverband (2012) Ganz normal für die gesetzlichen Kassen: 663.114-mal hat die GKV im Jahr 2010 die Krankenhausbehandlung von Knochenbrüchen finanziert

    Google Scholar 

  2. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s–6249s

    Article  Google Scholar 

  3. Macedo F et al (2017) Bone metastases: an overview. Oncol Rev 11(1):321

    PubMed  PubMed Central  Google Scholar 

  4. Bryson DJ, Wicks L, Ashford RU (2015) The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon. Injury 46(10):1891–1899

    Article  CAS  Google Scholar 

  5. Kendal JK et al (2018) A scoping review on the surgical management of metastatic bone disease of the extremities. BMC Musculoskelet Disord 19(1):279

    Article  Google Scholar 

  6. Kelley LM et al (2020) Pathological fracture and prognosis of high-grade osteosarcoma of the extremities: an analysis of 2,847 consecutive cooperative Osteosarcoma Study Group (COSS) patients. J Clin Oncol 38(8):823–833

    Article  Google Scholar 

  7. Jackson WF et al (2007) Early management of pathological fractures in children. Injury 38(2):194–200

    Article  CAS  Google Scholar 

  8. Anract P, Biau D, Boudou-Rouquette P (2017) Metastatic fractures of long limb bones. Orthop Traumatol Surg Res 103(1S):S41–S51

    Article  CAS  Google Scholar 

  9. Hoeller U et al (2021) Late sequelae of radiotherapy - the effect of technical and conceptual innovations in radiation oncology. Dtsch Arztebl Int. https://doi.org/10.3238/arztebl.m2021.0024

    Article  PubMed  PubMed Central  Google Scholar 

  10. Thierfelder KM et al (2020) Bone tumors and metastases: tips for initial diagnosis and follow-up: update 2019. Radiologe 60(2):169–178

    Article  Google Scholar 

  11. Soldatos T et al (2013) Imaging differentiation of pathologic fractures caused by primary and secondary bone tumors. Eur J Radiol 82(1):e36–e42

    Article  Google Scholar 

  12. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350(16):1655–1664

    Article  CAS  Google Scholar 

  13. Glassou EN et al (2019) Delay in surgery, risk of hospital-treated infections and the prognostic impact of comorbidity in hip fracture patients. A Danish nationwide cohort study, 2005–2016. Clin Epidemiol 11:383–395

    Article  Google Scholar 

  14. Klestil T et al (2018) Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis. Sci Rep 8(1):13933

    Article  Google Scholar 

  15. Ma J, Tullius T, Van Ha TG (2019) Update on preoperative embolization of bone metastases. Semin Intervent Radiol 36(3):241–248

    Article  Google Scholar 

  16. Luksanapruksa P et al (2018) Systematic review and meta-analysis of effectiveness of preoperative embolization in surgery for metastatic spine disease. J Neurointerv Surg 10(6):596–601

    Article  Google Scholar 

  17. Joo MW et al (2018) Post-radiation sarcoma: a study by the Eastern Asian Musculoskeletal Oncology Group. PLoS ONE 13(10):e204927

    Article  Google Scholar 

  18. Le AN et al (2020) Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Breast Cancer Res Treat 181(1):181–188

    Article  CAS  Google Scholar 

  19. Clezardin P et al (2021) Bone metastasis: mechanisms, therapies and biomarkers. Physiol Rev 101(3):797–855

    Article  Google Scholar 

  20. Grimer RJ (2006) Size matters for sarcomas! Ann R Coll Surg Engl 88(6):519–524

    Article  Google Scholar 

  21. El-Galaly TC, Gormsen LC, Hutchings M (2018) PET/CT for staging; past, present, and future. Semin Nucl Med 48(1):4–16

    Article  Google Scholar 

  22. Paydary K et al (2019) The evolving role of FDG-PET/CT in the diagnosis, staging, and treatment of breast cancer. Mol Imaging Biol 21(1):1–10

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Tumororthopädie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland

    Arne Streitbürger, Markus Nottrott, Wiebke Guder, Lars Podleska & Jendrik Hardes

  2. Klinik für Unfall‑, Hand-, und Wiederherstellungschirurgie, Universitätsmedizin Essen, Essen, Deutschland

    Marcel Dudda

Authors
  1. Arne Streitbürger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Nottrott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wiebke Guder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Podleska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marcel Dudda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jendrik Hardes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arne Streitbürger.

Ethics declarations

Interessenkonflikt

A. Streitbürger, M. Nottrott, W. Guder, L. Podleska, M. Dudda und J. Hardes geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

M. Omar, Hannover

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Streitbürger, A., Nottrott, M., Guder, W. et al. Strategisches Vorgehen bei pathologischen Frakturen. Unfallchirurg 124, 687–694 (2021). https://doi.org/10.1007/s00113-021-01068-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00113-021-01068-6

Schlüsselwörter

Keywords

Search

Navigation